4.1 Fixation for IHC

Immunohistochemistry does not begin at the stainer. It begins when blood supply stops and a piece of human tissue starts to die. Fixation is the chemical decision that halts autolysis, locks proteins in place, and decides whether an epitope will still be there when an antibody arrives days later. Independent OpenExamPrep study material for QIHC specimen handling treats 10% neutral buffered formalin (NBF) as the routine gold-standard fixative, then explains how clock time, specimen thickness, alternative chemicals, and decalcification change the stained result.

Why 10% NBF is the routine IHC gold standard

10% formalin is a 1:10 dilution of commercial concentrated formalin (approximately 37% to 40% formaldehyde). The working solution therefore contains about 3.7% to 4.0% formaldehyde, not 10% formaldehyde by weight. NBF adds phosphate buffer so pH stays near 7.0 to 7.4. Unbuffered formalin oxidizes to formic acid, the pH falls, and brown-black acid hematin (formalin pigment) deposits in blood-rich tissue. Acid conditions also alter some epitopes. Buffering is part of why NBF became the default for diagnostic FFPE IHC, not a cosmetic preference.

Formaldehyde is a small molecule. It penetrates tissue on the order of 1 mm per hour, slower in fat, skin, and clotted blood. Penetration is not completion. After the molecule arrives it must form adducts and then cross-links. A cassette can look wet with formalin while the center is still chemically native. Practical grossing therefore slices specimens about 5 mm thick (breast HER2 documents also describe 5 to 10 mm intervals after margin designation), uses a fixative-to-tissue volume of at least 10:1 and often 15:1 to 20:1, and avoids packing fatty breast into a cassette so tightly that formalin cannot circulate. Remote operating rooms should bisect a tumor and ship it immersed in NBF, not in a dry cup.

NBF is also the fixative named in ASCO/CAP breast-biomarker handling statements for estrogen receptor (ER), progesterone receptor (PR), and HER2. Those numeric windows are clinical-guideline source material. They are not text copied from an ASCP topic outline. Other fixatives can make a beautiful H&E slide and still be the wrong chemistry for a validated IHC assay.

Methylene bridges and antigen masking

Formaldehyde first adds to nucleophilic amino-acid side chains, especially the ε-amino group of lysine, forming hydroxymethyl adducts. Those adducts then condense into methylene bridges that cross-link proteins to each other and to the extracellular matrix. Cross-linking is the feature, not a side effect: enzymes stop, cells keep their shape through alcohol and hot paraffin, and the block can be stored.

The same bridges mask epitopes. An antibody raised against a native peptide may no longer fit if the epitope is chemically modified or buried under a mesh of cross-links. Heat-induced epitope retrieval later in the IHC protocol is largely an attempt to reverse a portion of that masking. Enzyme retrieval attacks the protein matrix a different way. Either way, fixation time and retrieval intensity are a pair. Short fixation plus harsh retrieval can destroy poorly cross-linked tissue. Long fixation plus weak retrieval can leave a true-positive epitope invisible.

Masking is expected with NBF. It is not proof that the clone is defective. Different antigens tolerate methylene bridging differently. Many intermediate filaments remain detectable after routine overnight NBF. Some phosphoproteins, some membrane receptors, and the nuclear hormone receptors used as breast predictive markers are less forgiving of delay before formalin and of extreme cross-linking after it.

Cold ischemia: surgery to fixative

Cold ischemia time is the interval from surgical removal (or loss of perfusion) to immersion in fixative. The specimen is called cold because it is no longer perfused at body temperature. Refrigeration is not required for the term to apply, and refrigeration does not reset the clock to zero. Residual phosphatases, proteases, and nucleases keep working. Phospho-epitopes disappear. Some membrane proteins degrade or change distribution. RNA falls quickly, which matters when the same block must also support in situ hybridization.

Operational causes of long cold ischemia include a specimen left on the back table until the case ends, a dry gauze wrap, a saline-filled cup that is not fixative, and a remote site that ships an intact fatty breast overnight without formalin. ASCO/CAP breast guidance for ER, PR, and HER2 asks that this interval be as short as possible and not more than 1 hour, and that the laboratory record the time tissue left the patient, the time it entered NBF, the fixative type, and the duration of fixation. CAP laboratory accreditation context for those predictive reports includes documenting cold ischemia and fixative type. Teach those numbers as ASCO/CAP breast-biomarker handling rules that QIHC technologists must know because they run the assays, not as ASCP outline wording.

ASCO/CAP breast ER, PR, and HER2: 6 to 72 hours in 10% NBF

After immersion, ASCO/CAP tissue-handling recommendations for breast ER, PR, and HER2 specify 10% NBF for 6 to 72 hours. The clock starts when the tissue enters formalin, not when the processor program later begins. A core biopsy still needs the 6-hour minimum; small size does not authorize a 90-minute rush if that block will carry predictive IHC. Current HER2 recommendation summaries use the same 6–72 hour window. Some older HER2 FAQ language discussed a 6–48 hour upper bound. Independent QIHC study material follows the 6–72 hour interval in current ASCO/CAP breast-biomarker publications and reminds staff to use the laboratory's validated procedure and the live guideline text for the assay on the bench.

The 6-hour floor exists because underfixed breast tissue produces false-negative or weak nuclear ER/PR and unreliable HER2 membrane staining. The 72-hour ceiling exists because prolonged methylene bridging can reduce immunoreactivity. A negative predictive result after fixation well beyond 72 hours should carry that limitation; HER2 ISH or another method may be considered. Exceptions to the handling process should appear in the report.

ASCO/CAP HER2 handling also states that cytology specimens must be formalin-fixed when used for that assay. Alcohol-only cytology fixation is a different chemistry; logistics of cytology specimens are covered in the special-specimen chapter. Unstained slides cut more than 6 weeks before analysis are not recommended for these breast markers. That antigenicity issue is introduced here and taught as a cutting-and-storage skill in the microtomy section.

Underfixation versus overfixation

Underfixation is incomplete cross-linking. Classically the rim of a large or fatty specimen is firm and stains, while the center stays soft, shows smudged nuclei, and takes eosin poorly. IHC in that center can be falsely weak or negative. Retrieval may lift or digest the poorly fixed tissue, creating holes and edge artifact. Underfixed cores rushed onto a same-day processor are a recurring source of puzzles in which the control stained and the patient did not—often not an antibody failure.

Overfixation is excess time in aldehyde after the tissue is already adequately cross-linked. Morphology is often excellent: crisp nuclei, easy sectioning until the block becomes hard. IHC may be dull even after aggressive retrieval because epitopes are tightly masked. Overfixation is not any NBF time past 6 hours. Overnight fixation of a 3 mm biopsy sits inside the 6–72 hour breast window. A specimen forgotten in a bucket for two weeks does not.

Both errors are time-and-geometry problems: cassette packing, weekend delay before grossing a large resection, and assuming a full container equals a complete chemical reaction. Recording start and stop times lets the IHC bench interpret a weak stain instead of only repeating it.

Alternative fixatives: Bouin, Zenker, B5, alcohol, and glyoxal

Beautiful H&E is not the same as validated IHC chemistry.

• Bouin's (picric acid, formaldehyde, and acetic acid) yields bright cytoplasmic and nuclear detail and is a traditional companion to gastrointestinal biopsies and trichrome. Picric acid must be washed out; dry picric salts are an explosion hazard. Bouin's extracts nucleic acids and can weaken IHC and ISH. It is not the ASCO/CAP fixative for breast ER/PR/HER2.
• Zenker's (mercuric chloride, potassium dichromate, acetic acid) and Helly's (Zenker-formol) give sharp nuclear detail. Mercury pigment is removed with iodine and thiosulfate. Mercury is hazardous waste. These fluids are largely retired and are not drop-in NBF replacements for predictive IHC.
• B5 (mercuric chloride, sodium acetate, formalin) was prized in hematopathology for chromatin and lymphocyte membranes. Most laboratories moved to zinc formalin or proprietary B-plus substitutes because of mercury. Historic B5 lymphoma blocks may need protocol notes; new solid-tumor predictive assays should not be validated only on mercury fixatives.
• Alcohols (ethanol, methanol; acetone in some cytology settings) are coagulative. They precipitate proteins rather than building methylene bridges. Shrinkage is greater. Some epitopes that formalin masks remain open; some membrane architecture changes. Alcohol-fixed cytology is not automatically equivalent to an NBF FFPE control. Nucleic acids may fare better in alcohol, which is why some molecular workflows prefer it while predictive IHC handling statements name formalin.
• Glyoxal (a two-carbon dialdehyde in several formalin-substitute products) cross-links differently from formaldehyde. Odor and formaldehyde vapor drop, which helps grossing-room exposure. Clones and retrieval conditions optimized on NBF often shift on glyoxal-fixed tissue. Switching to glyoxal is a fixative change and requires IHC revalidation. Breast ER/PR/HER2 handling statements specify 10% NBF.

Zinc formalin and alcoholic formalin also change penetration and cross-linking. The QIHC-safe default remains: routine gold standard = 10% NBF; everything else is an alternative with documented caveats.

Decalcification: acids versus EDTA versus IHC and ISH

Calcium must come out of bone and some calcified tumors before a safe ribbon can be cut. Strong mineral acids (hydrochloric, nitric) work in minutes to a few hours. They hydrolyze DNA and RNA and can abolish or weaken many epitopes. ISH after harsh acid decalcification often fails outright. Robust cytokeratins may still stain; many nuclear antigens and HER2 ISH will not.

Formic acid is gentler than hydrochloric or nitric acid but is still an acid. Use the shortest time that permits sectioning.

EDTA chelates calcium. It is slow—often a day or longer unless heat or agitation is added—and much kinder to proteins and nucleic acids. When the clinical question needs IHC or ISH on bone (metastatic carcinoma markers, hematolymphoid panels, HER2 ISH), EDTA or a validated EDTA-based system is the method to prefer.

Proprietary rapid decalcifiers are frequently acid-based even when the label emphasizes speed. The IHC bench should know which chemical and how long, not only that the specimen was decalcified. A negative ER or immunoglobulin light-chain stain on acid-decalcified bone is not equivalent to the same stain on an NBF soft-tissue block.

Prefixation versus postfixation

Prefixation is everything that happens before the intended primary fixative does its job. For routine FFPE IHC, the important prefixation interval is cold ischemia: dry pans, saline, and delayed immersion. Holding media designed for immunofluorescence (for example Michel's transport) are a different prefixation path and belong with immunofluorescence specimens. Prefixation does not gently start NBF chemistry; it is usually unfixed enzymatic time.

Postfixation is additional fixation after the primary fixative or after another preparatory step. Examples include postfixing a frozen section in NBF, acetone, or alcohol before IHC; moving formalin-fixed tissue into Bouin's for a special stain; and exposing already cut slides to formalin vapor. Postfixation changes epitope chemistry. An assay validated on NBF-only FFPE is not automatically valid on a postfixed block. Secondary formalin after a long delay also cannot resurrect epitopes that autolysis already destroyed; it may merely firm a degraded center. Frozen-section postfixation recipes are expanded in the frozen-specimen section; the fixation principle is the same: a second chemical is a new preanalytic variable.

Ask these questions before blaming the vial:

1. How long was cold ischemia, and was it documented?
2. Was the fixative 10% NBF or something else?
3. Was NBF time inside or outside 6–72 hours when breast predictive markers are in play?
4. Was a second fixative applied?
5. Was bone acid-decalcified or EDTA-decalcified?

If those answers are wrong, polymer detection and a new clone will not repair the specimen.